Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: Evidence for an important genetic-environmental interaction

Blood

Volumn 91, Issue 11, 1998, Pages 4158-4163

  Girelli, Domenico ^a,b   Friso, Simonetta ^a   Trabetti, Elisabetta ^a   Olivieri, Oliviero ^a   Russo, Carla ^a   Pessotto, Renzo ^a   Faccini, Giovanni ^a   Pignatti, Pier Franco ^a   Mazzucco, Alessandro ^a   Corrocher, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b POLICLINICO BORGO ROMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTINE; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

ADULT; AGED; ARTICLE; CONFORMATIONAL TRANSITION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; ENZYME CONFORMATION; FEMALE; FOLIC ACID BLOOD LEVEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOCYSTINURIA; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PRIORITY JOURNAL; RISK FACTOR; ALLELE; ANGIOCARDIOGRAPHY; ARTERIOSCLEROSIS; BLOOD; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PHENOTYPE;

ADULT; ALLELES; ARTERIOSCLEROSIS; CORONARY ANGIOGRAPHY; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; ITALY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PHENOTYPE; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 0032081312     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4158     Document Type: Article

References (41)

1. Mudd SH, Levy HL, Skovby F: Disorder of transsulfuration, in Scriver CR, Beaudet AL, Sly WS, Valle D, Scriver CR, Beaudet AL, Sly WS, Valles D (eds): The Metabolic Basis of Inherited Disease. New York, NY, McGraw-Hill, 1995, p 1279
2. McCully KS: Vascular pathology of homocysteinemia. Am J Pathol 56:111, 1969
3. Wilcken DEL, Wilcken B: The pathogenesis of coronary artery disease: A possible role for methionine metabolism. J Clin Invest 57:1079, 1976
4. Ueland PM, Refsum H, Brattstrom L: Plasma homocysteine and vascular disease, in Francis RB Jr (ed): Atherosclerotic Cardiovascular Disease. Haemostasis and Endothelial Function. New York, NY, Marcel Dekker, 1992, p 183
5. D'Angelo A, Selhub J: Homocysteine and thrombotic disease. Blood 90:1, 1997
6. Boers GHJ: Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thromb Haemost 77:520, 1997
7. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG: A quantitative assessement of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049, 1995
8. Nygård O, Nordrehaug JE, Refsum E, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230, 1997
9. Kang S-S, Zhou J, Wong PWK, Kowalisyn J, Strokosch G: Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414, 1988
10. Kang S-S, Passen EL, Ruggie N, Wong PWK, Sora H: Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 88:1463, 1993
11. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GHJ, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: Identification of a candidate genetic risk factor for vascular disease: A common mutation at the methylenetetrahydrofolate reductase locus. Nat Genet 10:111, 1995
12. Rozen R: Genetic predisposition to hyperhomocysteinemia: Deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 77:523, 1997
13. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7, 1996
14. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43, 1987
15. Kluijtmans LAJ, Van den Heuvel LPWJ, Boers GHJ, Frosst P, Van Oost BA, den Heijer M, Stevens EMB, Trijbels JMF, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58:35, 1996
16. Gallagher PM, Meleady R, Shields DC, Soon Tan K, McMaster D, Rozen R, Evans A, Graham IM, Whitehead AS: Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation 94:2154, 1996
17. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y: Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95:2032, 1997
18. Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ: Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med 89:437, 1996
19. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R: Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94:2410, 1996
20. Schwartz SM, Siscovick DS, Malinow RM, Rosendaal FR, Beverly RK, Hess DL, Psaty BM, Longstreth WT, Koepsell TD, Raughunathan TE, Reitsma PH: Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 96:412, 1997
21. Schmitz C, Lindpaintner K, Verhoef P, Graziano JM, Buring J: Genetic polymorphysm of methylenetetrahydrofolate reductase and myocardial infarction. A case control study. Circulation 94:1812, 1996
22. Brugada R, Marian J: A common mutation in methylenetetrahydrofolate reductase gene is not a major risk factor of coronary artery disease or myocardial infarction. Atherosclerosis 128:107, 1997
23. Christensen B, Frosst P, Lussier-Cacan S, Shelub J, Goyette P, Rosenblatt DS, Genest J, Rozen R: Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vase Biol 17:569, 1997
24. van Bockxmeer FM, Mamotte CD, Vasikaran SD, Taylor RR: Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 95:21, 1997
25. 677T mutation. Arterioscler Thromb Vase Biol 16:878, 1996
26. Verhoef P, Kok FJ, Kluijtmans LAJ, Blom HJ, Refsum H, Ueland PM, Kruyssen DACM: The 677 C→T mutation in the methylenetetrahydrofolate reductase gene: Associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132:105, 1997
27. Motulsky AG: Nutritional ecogenetics: Homocysteine-related aneriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58:17, 1996
28. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heijer M, Rozen R, Blom HJ: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070, 1995
29. De Franchis R, Mancini FP, D'Angelo A, Sebastio G, Fermo I, De Stefano V, Margaglione M, Mazzola G, Di Minno G, Andria G: Elevated total plasma homocysteinemia and 677 C→T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59:264, 1996 (letter)
30. 677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost 78:963, 1997 (letter)
31. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 265:2037, 1994
32. Kang, S-S, Wong PWK, Susmano A, Sora H, Norusis M, Ruggie N: Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 48:536, 1991
33. Rozen R: Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clin Invest Med 19:171, 1996
34. Lewis CA, Pancharuniti N, Sauberlich HE: Plasma folate adequacy as determined by homocysteine level. Ann NY Acad Sci 669:360, 1992
35. Oakley GP Jr, Adams MJ, Dickinson CM: More folic acid for everyone, now. J Nutr 126:7515, 1996
36. Guttormsen AB, Ueland PM, Nesthus I, Nygård, O, Schneede J, Vollset SE, Refsum H: Determinants and vitamin responsivness of intermediate hyperhomocysteinemia (≥40 μmol/liter). The Hordaland homocysteine study. J Clin Invest 98:2174, 1996
37. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Andreson PH, Seltzer D, Upson B, Lin QR: The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vase Biol 17:1157, 1997
38. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM: Thermolabile variant of the 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake and recommendations. Lancet 349:1591, 1997
39. Fermo I, D'Angelo SV, Paroni R, Mazzola G, Calori G, D'Angelo A: Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 123:747, 1995
40. The European Concerted Action Project: Graham IM, Daly LE, Retsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GHJ, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Lúis AC, Parrot-Roulaud FM, Soon Tan K, Higgins I, Garcon D, Medrano MJ, Candito M, Evans AE. Andria G: Plasma homocysteine as a risk factor for vascular disease. JAMA 277:1775, 1997
41. Miller JW, Nadeau MR, Smith D, Selhub J: Vitamin B-6 deficiency vs folate deficiency: Comparison of responses to methionine loading in rats. Am J Clin Nutr 59:1033, 1994